Skip to main content
Erschienen in: Quality of Life Research 12/2020

02.11.2020 | Brief Communication

Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer

verfasst von: Carmen Viada, Carlos Bouza, Martha Fors, Aliuska Frías, Mabel Alvarez, Lázara García, Bárbara Wilkinson, Camilo Rodríguez, Tania Crombet, Javier Ballesteros

Erschienen in: Quality of Life Research | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Quality of Life Core Questionnaire of the European Organization for the Research and Treatment of Cancer (EORTC QLQ-C30) is one of the most used quality of life questionnaires in cancer studies. It provides scores for five functional scales, nine symptom scales, and two single items which assess overall health status and quality of life. However, high correlations among QLQ-C30 items suggest a reduced dimensionality for the scale.

Objective

To assess the dimensionality of the EORTC QLQ-C30 using item response theory (IRT) in a training sample and confirmatory factor analysis (CFA) in a test sample.

Methods

We analyzed responses to QLQ-C30 from 1,107 patients with advanced lung cancer who were included in five clinical trials of immunotherapy. We used non-parametric and parametric IRT models (Mokken, and Samejima's graded response) in a random training set (n = 332) for initial assessment of dimensions and item characteristics of the QLQ-C30. Finally, we used CFA in the test set (n = 775) to confirm the measurement domains.

Results

Mokken model showed that QLQ-C30 fits a unidimensional scale, whereas Samejima model showed that most QLQ-C30 items present adequate difficulty and discrimination. All items showed adequate scalability indexes with an overall scalability of 0.47 (medium scale). The QLQ-C30-reduced dimensionality was confirmed by CFA (comparative fit index = 0.98, root mean square error of approximation = 0.055) with all items presenting factorial loadings > 0.40.

Conclusions

The EORTC QLQ-C30 fits a unidimensional latent construct identified with perceived quality of life in advanced lung cancer patients.

Trial registration

RPCEC00000161, RPCEC00000181 and RPCEC00000205
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Braun, D. P., Gupta, D., & Staren, E. D. (2011). Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer, 11(1), 353.PubMedPubMedCentralCrossRef Braun, D. P., Gupta, D., & Staren, E. D. (2011). Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer, 11(1), 353.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Gupta, D., Braun, D. P., & Staren, E. D. (2012). Association between changes in quality of life scores and survival in non-small cell lung cancer patients. European Journal Cancer Care, 21(5), 614–622.CrossRef Gupta, D., Braun, D. P., & Staren, E. D. (2012). Association between changes in quality of life scores and survival in non-small cell lung cancer patients. European Journal Cancer Care, 21(5), 614–622.CrossRef
3.
Zurück zum Zitat Li, T.-C., Li, C.-I., Tseng, C.-H., et al. (2012). Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health, 12(1), 1–1.CrossRef Li, T.-C., Li, C.-I., Tseng, C.-H., et al. (2012). Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health, 12(1), 1–1.CrossRef
4.
Zurück zum Zitat Ediebah, D. E., Coens, C., Zikos, E., et al. (2014). Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. British Journal of Cancer, 110(10), 2427–2433.PubMedPubMedCentralCrossRef Ediebah, D. E., Coens, C., Zikos, E., et al. (2014). Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. British Journal of Cancer, 110(10), 2427–2433.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Damm, K., Roeske, N., & Jacob, C. (2013). Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Economics Review, 3(1), 1–1.CrossRef Damm, K., Roeske, N., & Jacob, C. (2013). Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Economics Review, 3(1), 1–1.CrossRef
6.
Zurück zum Zitat Bouazza, Y. B., Chiairi, I., El Kharbouchi, O., et al. (2017). Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review. Lung Cancer, 113, 140–151.PubMedCrossRef Bouazza, Y. B., Chiairi, I., El Kharbouchi, O., et al. (2017). Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review. Lung Cancer, 113, 140–151.PubMedCrossRef
7.
Zurück zum Zitat Fayers, P., & Bottomley, A. (2002). Quality of life research within the EORTC—the EORTC QLQ-C30. European Journal of Cancer, 38, 125–133.CrossRef Fayers, P., & Bottomley, A. (2002). Quality of life research within the EORTC—the EORTC QLQ-C30. European Journal of Cancer, 38, 125–133.CrossRef
8.
Zurück zum Zitat Cocks, K., King, M. T., Velikova, G., et al. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology, 29(1), 89–96.PubMedCrossRef Cocks, K., King, M. T., Velikova, G., et al. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology, 29(1), 89–96.PubMedCrossRef
9.
Zurück zum Zitat Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef
10.
Zurück zum Zitat Nicklasson, M., & Bergman, B. (2007). Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Quality of Life Research, 16(6), 1019–1028.PubMedCrossRef Nicklasson, M., & Bergman, B. (2007). Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Quality of Life Research, 16(6), 1019–1028.PubMedCrossRef
11.
Zurück zum Zitat Costa, D. S. J., Aaronson, N. K., Fayers, P. M., et al. (2014). Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis. Quality of Life Research, 24(1), 125–133.PubMedCrossRef Costa, D. S. J., Aaronson, N. K., Fayers, P. M., et al. (2014). Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis. Quality of Life Research, 24(1), 125–133.PubMedCrossRef
12.
Zurück zum Zitat Osoba, D., Zee, B., Pater, J., et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Quality of Life Research, 3(5), 353–364.PubMedCrossRef Osoba, D., Zee, B., Pater, J., et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Quality of Life Research, 3(5), 353–364.PubMedCrossRef
13.
Zurück zum Zitat Cocks, K., King, M. T., Velikova, G., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.PubMedCrossRef Cocks, K., King, M. T., Velikova, G., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.PubMedCrossRef
14.
Zurück zum Zitat Bedard, G., Zeng, L., Zhang, L., et al. (2013). Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer. Asia-Pac Journal of Clinical Oncology, 10(2), 109–117.CrossRef Bedard, G., Zeng, L., Zhang, L., et al. (2013). Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer. Asia-Pac Journal of Clinical Oncology, 10(2), 109–117.CrossRef
15.
Zurück zum Zitat Maringwa, J. T., Quinten, C., King, M., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.PubMedCrossRef Maringwa, J. T., Quinten, C., King, M., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.PubMedCrossRef
16.
Zurück zum Zitat Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). EORTC QLQ-C30 Scoring Manual (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer. Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). EORTC QLQ-C30 Scoring Manual (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer.
17.
Zurück zum Zitat Shih, C.-L., Chen, C.-H., Sheu, C.-F., Lang, H.-C., & Hsieh, C.-L. (2013). Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model. Value Health, 16(5), 848–854.PubMedCrossRef Shih, C.-L., Chen, C.-H., Sheu, C.-F., Lang, H.-C., & Hsieh, C.-L. (2013). Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model. Value Health, 16(5), 848–854.PubMedCrossRef
18.
Zurück zum Zitat van der Kloot, W. A., Kobayashi, K., Yamaoka, K., et al. (2014). Summarizing the fifteen scales of the EORTC QLQ-C30 Questionnaire by five aggregate scales with two underlying dimensions: A literature review and an empirical study. Journal of psychosocial oncology, 32(4), 413–430.PubMedCrossRef van der Kloot, W. A., Kobayashi, K., Yamaoka, K., et al. (2014). Summarizing the fifteen scales of the EORTC QLQ-C30 Questionnaire by five aggregate scales with two underlying dimensions: A literature review and an empirical study. Journal of psychosocial oncology, 32(4), 413–430.PubMedCrossRef
19.
Zurück zum Zitat Gundy, C. M., Fayers, P. M., Groenvold, M., et al. (2011). Comparing higher order models for the EORTC QLQ-C30. Quality of Life Research, 21(9), 1607–1617.PubMedPubMedCentralCrossRef Gundy, C. M., Fayers, P. M., Groenvold, M., et al. (2011). Comparing higher order models for the EORTC QLQ-C30. Quality of Life Research, 21(9), 1607–1617.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Giesinger, J. M., Kieffer, J. M., Fayers, P. M., et al. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.PubMedCrossRef Giesinger, J. M., Kieffer, J. M., Fayers, P. M., et al. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.PubMedCrossRef
21.
Zurück zum Zitat Vinageras, E. N., de la Torre, A., Rodríguez, M. O., et al. (2008). Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non–small-cell lung cancer. Journal of Clinical Oncology, 26(9), 1452–1458.CrossRef Vinageras, E. N., de la Torre, A., Rodríguez, M. O., et al. (2008). Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non–small-cell lung cancer. Journal of Clinical Oncology, 26(9), 1452–1458.CrossRef
22.
Zurück zum Zitat Rodriguez, P. C., Popa, X., Martinez, O., et al. (2016). A Phase III clinical trial of the epidermal growth factor vaccine CIMAvax-EGF as switch maintenance therapy in advanced non-small cell lung cancer patients. Clinical Cancer Research, 22(15), 3782–3790.PubMedCrossRef Rodriguez, P. C., Popa, X., Martinez, O., et al. (2016). A Phase III clinical trial of the epidermal growth factor vaccine CIMAvax-EGF as switch maintenance therapy in advanced non-small cell lung cancer patients. Clinical Cancer Research, 22(15), 3782–3790.PubMedCrossRef
23.
Zurück zum Zitat Hernandez, M., Ortiz, R. A., Neninger, E., et al. (2016). P2.40: CIMAvaxEGF vaccine for the treatment of real-world NSCLC patients. Journal of Thoracic Oncology, 11(10), S242.CrossRef Hernandez, M., Ortiz, R. A., Neninger, E., et al. (2016). P2.40: CIMAvaxEGF vaccine for the treatment of real-world NSCLC patients. Journal of Thoracic Oncology, 11(10), S242.CrossRef
24.
Zurück zum Zitat Molenaar I. W. (1997) Nonparametric models for polytomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 369–380). New York, NY: Springer New York.CrossRef Molenaar I. W. (1997) Nonparametric models for polytomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 369–380). New York, NY: Springer New York.CrossRef
25.
Zurück zum Zitat Mokken R. J. (1997) Nonparametric models for dichotomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 351–367). New York, NY: Springer New York. CrossRef Mokken R. J. (1997) Nonparametric models for dichotomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 351–367). New York, NY: Springer New York. CrossRef
26.
Zurück zum Zitat Brown, T. A. (2006). Confirmatory factor analysis for applied research. New York: The Guilford Press. Brown, T. A. (2006). Confirmatory factor analysis for applied research. New York: The Guilford Press.
30.
Zurück zum Zitat Rizopoulos, D. (2006). ltm: An RPackage for latent variable modeling and item response theory analyses. Journal of Statistical Software, 17(5), 1–25.CrossRef Rizopoulos, D. (2006). ltm: An RPackage for latent variable modeling and item response theory analyses. Journal of Statistical Software, 17(5), 1–25.CrossRef
31.
Zurück zum Zitat Rosseel, Y. (2012). lavaan: An RPackage for structural equation modeling. Journal of Statistical Software, 48(2), 1–36.CrossRef Rosseel, Y. (2012). lavaan: An RPackage for structural equation modeling. Journal of Statistical Software, 48(2), 1–36.CrossRef
32.
Zurück zum Zitat Petersen, M. A., Groenvold, M., Aaronson, N., et al. (2006). Item response theory was used to shorten EORTC QLQ-C30 scales for use in palliative care. Journal of Clinical Epidemiology, 59(1), 36–44.PubMedCrossRef Petersen, M. A., Groenvold, M., Aaronson, N., et al. (2006). Item response theory was used to shorten EORTC QLQ-C30 scales for use in palliative care. Journal of Clinical Epidemiology, 59(1), 36–44.PubMedCrossRef
33.
Zurück zum Zitat Arraras, J. I., Suárez, J., Arias de la Vega, F., et al. (2011). The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clinical and Translational Oncology, 13(1), 50–56.PubMedCrossRef Arraras, J. I., Suárez, J., Arias de la Vega, F., et al. (2011). The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clinical and Translational Oncology, 13(1), 50–56.PubMedCrossRef
34.
Zurück zum Zitat Arraras Urdaniz, J. I., Villafranca Iturre, E., Arias de la Vega, F., et al. (2008). The EORTC quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Archivos Espanoles de Urologia, 61(8), 949–954.PubMed Arraras Urdaniz, J. I., Villafranca Iturre, E., Arias de la Vega, F., et al. (2008). The EORTC quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Archivos Espanoles de Urologia, 61(8), 949–954.PubMed
35.
Zurück zum Zitat Scott, N. W., Fayers, P. M., Bottomley, A., et al. (2006). Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses. Quality of Life Research, 15(6), 1103–1115.PubMedCrossRef Scott, N. W., Fayers, P. M., Bottomley, A., et al. (2006). Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses. Quality of Life Research, 15(6), 1103–1115.PubMedCrossRef
Metadaten
Titel
Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer
verfasst von
Carmen Viada
Carlos Bouza
Martha Fors
Aliuska Frías
Mabel Alvarez
Lázara García
Bárbara Wilkinson
Camilo Rodríguez
Tania Crombet
Javier Ballesteros
Publikationsdatum
02.11.2020
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 12/2020
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02584-5

Weitere Artikel der Ausgabe 12/2020

Quality of Life Research 12/2020 Zur Ausgabe